**Abstract**

**Background:** Mismatch negativity (MMN) is a component of auditory event-related potentials that reflect automatic change detection in brain, showing qualities of endophenotypes in schizophrenia. MMN deficiency is one of the robust findings in the patients, and reflects cognitive and functional decline.

The Catechol-O-methyltransferase (COMT) is a key enzyme involved in regulating dopamine transmission within the prefrontal cortex. Preliminary study suggested that COMTVal108/158Met genotype is related to cognitive function in schizophrenia. Both related to cognitive function, however, no studies have reported the relationship between MMN and COMTVal108/158Met genotype in schizophrenia. In this study, we examined the relationship between them.

**Method:** Duration MMN was measured, and COMTVal108/158Met polymorphism was detected by polymerase chain reaction- restriction fragment length polymorphism in 49 schizophrenia patients. (Val/Val, 21; Met carriers 28). The amplitude and latency of MMN were compared between the Val/Val and Met carriers.

**Results:** The MMN amplitudes in schizophrenia patients were no difference between Val/Val and Met carriers. The MMN latency of Met carriers was shorter than that of Val/Val.

**Conclusions:** It is known that the enzyme containing Met has less activity and presumably greater synaptic dopamine than the Val/Val enzyme. Therefore, these results mean that the dopamine activity in prefrontal cortex accelerates pre-attentive auditory change detection.
